Status:
COMPLETED
Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lymphoma
Eligibility:
All Genders
60-120 years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors understand how p...
Detailed Description
OBJECTIVES: * To construct tissue microarrays (TMA) using tissue samples from older patients with diffuse large B-cell lymphoma treated with standard CHOP chemotherapy (cyclophosphamide, doxorubicin,...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of diffuse large B-cell lymphoma
- Received treatment on clinical trial ECOG-E4494
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
September 24 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 24 2008
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT00898157
Start Date
September 24 2007
End Date
September 24 2008
Last Update
May 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.